Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03254524 · ClinicalTrials.gov registry record
Geography of ED Use and Population Health
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 100
- Enrollment target
NCT03254524: Completed study, sponsored by NYU Langone Health.
NCT03254524 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03254524 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The goal of this study is to create predictive models of emergency care and metrics for population health that can be used to analyze how events like hospital closures or disasters like Hurricane Sandy affect health care utilization by patients in specific populations or geographic regions. Additionally, it will allow the development of metrics for population health that can act as surveillance mechanisms to measure disease prevalence and identify patterns in emergency department use that can be used to identify specific geographic regions where health care is either optimized to promote health or needs to be improve so that population health can be improved.
Primary Outcome
In order to identify repeat ED visits by the same individual, unique identifiers within SPARCS match visits by the same individual throughout the study period
Interventions
- OTHER Statewide Planning and Research Cooperative System Database
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2014-08-20 |
| Est. Completion | 2020-12-31 |
What the finished NCT03254524 record still lists
NCT03254524 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Statewide Planning and Research Cooperative System Database is the first listed.
NCT03254524 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03254524 about?
NCT03254524 is a clinical study titled "Geography of ED Use and Population Health". The goal of this study is to create predictive models of emergency care and metrics for population health that can be used to analyze how events like hospital closures or disasters like Hurricane Sandy affect health care utilization by patients in specific populations or geographic regions. Addition...
What is the current status of trial NCT03254524?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2014-08-20. Estimated completion is 2020-12-31.
What interventions are being tested in trial NCT03254524?
The interventions under investigation include: Statewide Planning and Research Cooperative System Database (OTHER).
Who is sponsoring clinical trial NCT03254524?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI